NoticeThis is an independent non-profit initiative. We are not affiliated with the European Medicines Agency (EMA) or the official CTIS system. For the official EU Clinical Trials Information System, visit:
EMA Registry →
patients with estrogen receptor-positive/human epidermal growth factor
receptor 2-negative, ESR1-mutated, advanced breast cancer progressing to endocrine therapy
and CDK4/6 inhibitors.
1 total trials1 recruiting
Filter these 1 trials by phase, country, sponsor and more.